Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.1
4.7
Journals
Viruses
Special Issues
Structure-Guided Antiviral Discovery: From Target Validation to Drug Design to...
share announcement

Structure-Guided Antiviral Discovery: From Target Validation to Drug Design to Candidate Selection

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 1282

Special Issue Editor

Prof. Dr. Diane Joseph-McCarthy

E-Mail Website
Guest Editor
Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA
Interests: design and discovery of novel agents; binding site identification for proteins; epitope identification; drug delivery

Special Issue Information

Dear Colleagues,

In this era of data-driven drug discovery, structure-based computational approaches are increasingly employed to advance drug discovery, from target selection and validation, to drug design and optimization, to candidate selection. The number of drug targets for which structural data are available has proliferated due to advances in cryo-electron microscopy, as well as recent breakthroughs in the application of artificial intelligence (AI) in the prediction of structures from sequences. These structural insights have been critical for previously difficult targets, including many of those relevant to antiviral discovery. This Special Issue will highlight the utilization of structural data and the application and development of structure-guided approaches for the design of antiviral drugs. Articles that describe advances in structure determination related to viral pathogens, applications of novel structure-guided computational approaches that elucidate the mechanism of viral pathogenesis relevant to drug discovery, validate target selection, or accelerate antiviral design, and those that highlight case studies involving the use of structural data for antiviral discovery are within the scope of this Special Issue. In particular, the computational drug discovery technologies employed may include, but are not limited to, hot spot mapping, molecular docking, molecular dynamics, free energy perturbation, and artificial intelligence/machine learning approaches that utilize structural inputs or integrate a range of structural data.

We welcome submissions of cutting-edge primary research and reviews.

Prof. Dr. Diane Joseph-McCarthy
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

17 pages, 4334 KiB  
Article
Elucidating the Molecular Determinants of the Binding Modes of a Third-Generation HIV-1 Integrase Strand Transfer Inhibitor: The Importance of Side Chain and Solvent Reorganization
by Qinfang Sun, Avik Biswas, Dmitry Lyumkis, Ronald Levy and Nanjie Deng
Viruses 2024, 16(1), 76; https://0-doi-org.brum.beds.ac.uk/10.3390/v16010076 - 02 Jan 2024
Viewed by 1016
Abstract
The first- and second-generation clinically used HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) are key components of antiretroviral therapy (ART), which work by blocking the integration step in the HIV-1 replication cycle that is catalyzed by a nucleoprotein assembly called an intasome. However, [...] Read more.
The first- and second-generation clinically used HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) are key components of antiretroviral therapy (ART), which work by blocking the integration step in the HIV-1 replication cycle that is catalyzed by a nucleoprotein assembly called an intasome. However, resistance to even the latest clinically used INSTIs is beginning to emerge. Developmental third-generation INSTIs, based on naphthyridine scaffolds, are promising candidates to combat drug-resistant viral variants. Among these novel INSTIs, compound 4f exhibits two distinct conformations when binding with intasomes from HIV-1 and the closely related prototype foamy virus (PFV) despite the high structural similarity of their INSTI binding pockets. The molecular mechanism and the key active site residues responsible for these differing binding modes in closely related intasomes remain elusive. To unravel the molecular determinants governing the two distinct binding modes, we applied a novel molecular dynamics-based free energy method that utilizes alchemical pathways to overcome the sampling challenges associated with transitioning between the two bound conformations of ligand 4f within the crowded environments of the INSTI binding pockets in these intasomes. The calculated conformational free energies successfully recapitulate the experimentally observed binding mode preferences in the two viral intasomes. Analysis of the simulated structures suggests that the observed binding mode preferences are caused by amino acid residue differences in both the front and the central catalytic sub-pocket of the INSTI binding site in HIV-1 and PFV. Additional free energy calculations on mutants of HIV-1 and PFV revealed that while both sub-pockets contribute to binding mode selection, the central sub-pocket plays a more important role. These results highlight the importance of both side chain and solvent reorganization, as well as the conformational entropy in determining the ligand binding mode, and will help inform the development of more effective INSTIs for combatting drug-resistant viral variants. Full article
(This article belongs to the Special Issue Structure-Guided Antiviral Discovery: From Target Validation to Drug Design to Candidate Selection)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop